ADVERTISEMENT

ITC Q1 Review - Well-Played: ICICI Securities

ITC Q1 Review - Well-Played: ICICI Securities

Range of products manufactured by ITC Ltd. (Source: Company website)
Range of products manufactured by ITC Ltd. (Source: Company website)

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

ICICI Securities Report

ITC Ltd.'s cigarette volume rose ~30% y-o-y in Q1 FY22 (our view) – lower disruption in the second wave and a swift recovery post normalcy (versus last year) is reassuring (two year compound annual growth rate ~down 12%).

Fast moving consumer goods revenues grew up 10% y-o-y despite pockets of weakness; performance in the health and hygiene categories continued to be strong while it lapped a high base in staples and convenience foods.

Focus continued on augmenting distribution with FMCG segment seeing steady margin expansion.

We highlight that ITC has high revenue salience from south India and hence stricter lockdowns in Kerala and Tamil Nadu has likely impacted Q1 FY22 performance (one-off).

Click on the attachment to read the full report:

ICICI Securities ITC Q1FY22 Result Update.pdf

DISCLAIMER

This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.